Surgery Partners plans to offer $425 million in senior unsecured notes for general corporate purposes, including debt repayment.
Quiver AI Summary
Surgery Partners, Inc. announced its plan to offer an additional $425 million of 7.250% senior unsecured notes due in 2032 through its wholly owned subsidiary, Surgery Center Holdings, Inc. The proceeds from this offering will be used for general corporate purposes, including repaying debt. The notes will be guaranteed by domestic subsidiaries of the issuer. This offering is targeted at qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S, and will not be registered under the Securities Act. Surgery Partners, a significant player in outpatient surgical care with over 200 locations in 30 states, emphasizes its focus on high-quality, cost-effective surgical services. The company also includes forward-looking statements about the offering, acknowledging potential risks and uncertainties that could affect the outcomes.
Potential Positives
- Surgery Partners intends to raise $425.0 million through the offering of additional senior unsecured notes, which can strengthen its financial position.
- The proceeds from the notes will be used for general corporate purposes, including repaying outstanding borrowings, potentially reducing debt and improving liquidity.
- The company highlights its growth and market presence, being one of the largest and fastest growing surgical services businesses with over 200 locations across 30 states.
- The senior notes being issued will carry a fixed interest rate of 7.250%, which may be attractive to institutional investors, signaling confidence in the company's financial health.
Potential Negatives
- The company is increasing its debt by offering an additional $425 million in senior unsecured notes, which may raise concerns about its financial stability and ability to manage debt levels.
- The use of proceeds to repay outstanding borrowings suggests that the company might be experiencing liquidity issues.
- The mention of forward-looking statements includes a range of significant risks and uncertainties that could affect the success of the offering, potentially creating apprehension among investors.
FAQ
What is the purpose of Surgery Partners' new note offering?
Surgery Partners intends to use the net proceeds for general corporate purposes, including repaying outstanding borrowings.
How much is Surgery Partners planning to offer in senior unsecured notes?
The Company plans to offer an additional $425.0 million of its 7.250% senior unsecured notes due 2032.
Who can buy the senior unsecured notes being offered?
The notes are being offered only to qualified institutional buyers in the U.S. and non-U.S. persons outside the U.S.
When were the original senior notes issued?
The original 7.250% senior notes due 2032 were issued in April 2024.
Where is Surgery Partners headquartered?
Surgery Partners is headquartered in Brentwood, Tennessee, and operates over 200 locations across the United States.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SGRY Insider Trading Activity
$SGRY insiders have traded $SGRY stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $SGRY stock by insiders over the last 6 months:
- DAVID T DOHERTY (Chief Financial Officer) sold 47,491 shares for an estimated $1,110,814
- TERESA DELUCA sold 20,018 shares for an estimated $455,209
- PATRICIA ANNE MARYLAND sold 20,018 shares for an estimated $455,209
- HARRISON R. BANE (National Group President) has made 0 purchases and 2 sales selling 9,339 shares for an estimated $209,940.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SGRY Revenue
$SGRY had revenues of $821.5M in Q3 2025. This is an increase of 6.63% from the same period in the prior year.
You can track SGRY financials on Quiver Quantitative's SGRY stock page.
$SGRY Hedge Fund Activity
We have seen 105 institutional investors add shares of $SGRY stock to their portfolio, and 127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 7,091,756 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $157,649,735
- PENTWATER CAPITAL MANAGEMENT LP added 4,681,000 shares (+66.9%) to their portfolio in Q3 2025, for an estimated $101,296,840
- KING STREET CAPITAL MANAGEMENT, L.P. added 3,114,930 shares (+50.0%) to their portfolio in Q3 2025, for an estimated $67,407,085
- HEIN PARK CAPITAL MANAGEMENT LP removed 1,371,702 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,492,935
- UBS GROUP AG added 1,239,549 shares (+50.6%) to their portfolio in Q3 2025, for an estimated $26,823,840
- IRENIC CAPITAL MANAGEMENT LP added 1,132,203 shares (+inf%) to their portfolio in Q3 2025, for an estimated $24,500,872
- FARALLON CAPITAL MANAGEMENT LLC removed 1,054,170 shares (-54.7%) from their portfolio in Q3 2025, for an estimated $22,812,238
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SGRY Analyst Ratings
Wall Street analysts have issued reports on $SGRY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 11/17/2025
- UBS issued a "Buy" rating on 11/13/2025
To track analyst ratings and price targets for $SGRY, check out Quiver Quantitative's $SGRY forecast page.
$SGRY Price Targets
Multiple analysts have issued price targets for $SGRY recently. We have seen 7 analysts offer price targets for $SGRY in the last 6 months, with a median target of $29.0.
Here are some recent targets:
- Benjamin Rossi from JP Morgan set a target price of $20.0 on 11/24/2025
- Andrew Mok from Barclays set a target price of $18.0 on 11/21/2025
- Ann Hynes from Mizuho set a target price of $22.0 on 11/17/2025
- A.J. Rice from UBS set a target price of $29.0 on 11/13/2025
- Bill Sutherland from Benchmark set a target price of $30.0 on 11/11/2025
- Ben Hendrix from RBC Capital set a target price of $31.0 on 11/11/2025
- Sarah James from Cantor Fitzgerald set a target price of $36.0 on 10/07/2025
Full Release
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”). The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the Issuer’s 7.250% senior notes due 2032 originally issued in April 2024.
Surgery Partners intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, repaying outstanding borrowings under its revolving credit facility.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy securities, nor shall there be any offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such offer, solicitation or sale would be unlawful. The Notes and the Guarantees are being offered and sold only to persons reasonably believed to be “qualified institutional buyers” in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes and the Guarantees have not been, and will not be, registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Forward-Looking Statements
This press release contains forward-looking statements, including those regarding Surgery Partners’ intention to offer and sell, and apply the net proceeds of, the Notes. These statements include, but are not limited to, the Company’s expectations regarding the proposed offering. These statements can be identified by the use of words such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “continues,” “estimates,” “predicts,” “projects,” “forecasts,” and similar expressions. All forward-looking statements are based on current expectations and beliefs as of the date of this release and are subject to risks, uncertainties and other factors that may cause actual results to differ materially from the expectations discussed in, or implied by, the forward-looking statements. Many of these factors are beyond our ability to control or predict including, without limitation, the risk that the proposed offering is not completed on the terms or in the amounts anticipated, or at all, and the other risks and uncertainties identified and discussed in the Company’s reports filed with the SEC, including in Item 1A under the heading "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 7, 2025 and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025, filed on May 12, 2025, August 5, 2025 and November 10, 2025, respectively. Except as required by law, neither the Company nor the Issuer undertakes any obligation to revise or update publicly any forward-looking statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated events or circumstances.
Contact:
Surgery Partners Investor Relations
(615) 234-8940
[email protected]